GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
GlaxoSmithKline beat estimated earnings by 15.79%, reporting an EPS of $0.88 versus an estimate of $0.76.
Revenue was up $2.89 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 0.41% increase in the share price the next day.
Here's a look at GlaxoSmithKline's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.65 | 0.81 | 0.57 | 0.61 |
| EPS Actual | 0.69 | 1.01 | 0.79 | 0.63 |
| Revenue Estimate | 12.79B | 11.88B | 10.54B | 11.06B |
| Revenue Actual | 12.84B | 12.44B | 11.33B | 10.24B |
To track all earnings releases for GlaxoSmithKline visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
